Watkins PB - Search Results

1

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database.

Watkins PB, Lewis JH, Kaplowitz N, Alpers DH, Blais JD, Smotzer DM, Krasa H, Ouyang J, Torres VE, Czerwiec FS, Zimmer CA. Watkins PB, et al. Drug Saf. 2015 Nov;38(11):1103-13. doi: 10.1007/s40264-015-0327-3. Drug Saf. 2015. PMID: 26188764 Free PMC article.

2

Did this drug cause my patient's hepatitis?

Kaplowitz N, Lewis JH, Watkins PB. Kaplowitz N, et al. Among authors: watkins pb. Ann Intern Med. 2003 Jan 21;138(2):159-60; author reply 159-60. doi: 10.7326/0003-4819-138-2-200301210-00025. Ann Intern Med. 2003. PMID: 12529106 No abstract available.

3

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.

Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC. Watkins PB, et al. JAMA. 2006 Jul 5;296(1):87-93. doi: 10.1001/jama.296.1.87. JAMA. 2006. PMID: 16820551 Clinical Trial.

4

Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.

Watkins PB, Dube LM, Walton-Bowen K, Cameron CM, Kasten LE. Watkins PB, et al. Drug Saf. 2007;30(9):805-15. doi: 10.2165/00002018-200730090-00006. Drug Saf. 2007. PMID: 17722971 Clinical Trial.

5

Using controlled clinical trials to learn more about acute drug-induced liver injury.

Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR. Watkins PB, et al. Hepatology. 2008 Nov;48(5):1680-9. doi: 10.1002/hep.22633. Hepatology. 2008. PMID: 18853438

6

Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery.

Watkins PB, Desai M, Berkowitz SD, Peters G, Horsmans Y, Larrey D, Maddrey W. Watkins PB, et al. Drug Saf. 2011 Mar 1;34(3):243-52. doi: 10.2165/11586600-000000000-00000. Drug Saf. 2011. PMID: 21332248 Clinical Trial.

7

Case definition and phenotype standardization in drug-induced liver injury.

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Aithal GP, et al. Among authors: watkins pb. Clin Pharmacol Ther. 2011 Jun;89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4. Clin Pharmacol Ther. 2011. PMID: 21544079 Review.

8

Current challenges and controversies in drug-induced liver injury.

Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M. Corsini A, et al. Among authors: watkins pb. Drug Saf. 2012 Dec 1;35(12):1099-117. doi: 10.1007/BF03261997. Drug Saf. 2012. PMID: 23137150

9

Anti-tuberculosis drug-induced liver injury in Shanghai: validation of Hy's Law.

Shen X, Yuan Z, Mei J, Zhang Z, Guo J, Wu Z, Wu J, Zhang H, Pan J, Huang W, Gong H, Yuan D, Xiao P, Wang Y, Shuai Y, Lin S, Pan Q, Zhou T, Watkins PB, Wu F. Shen X, et al. Among authors: watkins pb. Drug Saf. 2014 Jan;37(1):43-51. doi: 10.1007/s40264-013-0119-6. Drug Saf. 2014. PMID: 24203912

10

Linking physiology to toxicity using DILIsym®, a mechanistic mathematical model of drug-induced liver injury.

Shoda LK, Woodhead JL, Siler SQ, Watkins PB, Howell BA. Shoda LK, et al. Among authors: watkins pb. Biopharm Drug Dispos. 2014 Jan;35(1):33-49. doi: 10.1002/bdd.1878. Epub 2013 Nov 25. Biopharm Drug Dispos. 2014. PMID: 24214486 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters